Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...

Missing data can plague researchers in many scenarios, arising from incomplete surveys, experimental objects broken or destroyed, or data collection/computational errors. This short course will ...

The report focused primarily on phase 3 confirmatory clinical trials for assessing the safety and efficacy of drugs, biologic products, and some medical devices, for which the bar of scientific rigor ...